BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36915143)

  • 21. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center.
    Dai Y; Dong Y; Cheng Y; Hou H; Wang J; Wang Z; Wang J
    J Gynecol Oncol; 2020 May; 31(3):e27. PubMed ID: 31912681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of omental disease and the role of omentectomy in non-endometrioid endometrial cancer.
    Seyfettinoglu S; Khatib G; Güleç ÜK; Güzel AB; Gümürdülü D; Vardar MA
    Ginekol Pol; 2023; 94(10):823-830. PubMed ID: 37599572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
    Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.
    Guntupalli SR; Zighelboim I; Kizer NT; Zhang Q; Powell MA; Thaker PH; Goodfellow PJ; Mutch DG
    Gynecol Oncol; 2012 Jan; 124(1):31-5. PubMed ID: 22030404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
    Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
    J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study.
    Pifer PM; Bhargava R; Patel AK; Ling DC; Vargo JA; Orr BC; Sukumvanich P; Courtney-Brooks MB; Boisen MM; Berger JL; Taylor S; Olawaiye AB; Comerci JT; Lesnock JL; Edwards RP; Beriwal S
    Gynecol Oncol; 2020 Oct; 159(1):23-29. PubMed ID: 32718729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
    Zhang C; Wang C; Feng W
    Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
    Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
    Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
    Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
    Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The struggle against endometrial cancer: ten years of experience of a tertiary center.
    Bilgi A; Guler AH; Kulhan M; Cintesun E; Ates M; Celik C
    Ginekol Pol; 2022; 93(5):351-360. PubMed ID: 34155618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer.
    Andrade DAP; da Silva VD; Matsushita GM; de Lima MA; Vieira MA; Andrade CEMC; Schmidt RL; Reis RM; Dos Reis R
    PLoS One; 2019; 14(10):e0220086. PubMed ID: 31600211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.
    Zhang C; Havrilesky LJ; Broadwater G; Di Santo N; Ehrisman JA; Lee PS; Berchuck A; Alvarez Secord A; Bean S; Bentley RC; Valea FA
    Gynecol Oncol; 2014 May; 133(2):211-5. PubMed ID: 24582867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer.
    Delvallée J; Cancel M; Body G; Bendifallah S; Touboul C; Dabi Y; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Ballester M; Carcopino X; Mimoun C; Darai E; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2021 Dec; 50(10):102193. PubMed ID: 34224900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer.
    van der Putten LJ; Geels YP; Ezendam NP; van der Putten HW; Snijders MP; van de Poll-Franse LV; Pijnenborg JM
    Int J Gynecol Cancer; 2015 Jan; 25(1):75-80. PubMed ID: 25356534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.
    Akar S; Çelik ZE; Fındık S; İlhan TT; Ercan F; Çelik Ç
    Int J Clin Oncol; 2020 Jan; 25(1):195-202. PubMed ID: 31452018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.